Anuh Pharma Declines 3.81%: Downgrade and Technical Shift Weigh on Shares
2026-11-21 15:00:42Key Events This Week 16 Nov: Stock opens at ₹81.67, down 1.03% on low volume 17 Nov: Downgrade to Sell rating announced 18 Nov: Technical momentum shifts to sideways trend 20 Nov: Week closes at ₹79.38, down 0.40% on final session Week Open₹81.67 Week Close₹79.38<div class="stat-change ne...
Read More
Anuh Pharma Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-11-18 08:35:01Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMojo as of 17 Nov 2026. This decision follows a comprehensive reassessment of the company’s quality, valuation, financial trend, and technical indicators, reflecting a cautious outlook despite some attractive valuation metrics.
Read More
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-18 08:04:05Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid mixed signals and recent price movements.
Read More
Anuh Pharma Ltd is Rated Hold by MarketsMOJO
2026-11-14 10:10:04Anuh Pharma Ltd is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 27 October 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-10-26 08:02:09Anuh Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, despite a recent downgrade in its Mojo Grade to Sell. This transition is underscored by a complex interplay of technical indicators, reflecting a nuanced market sentiment for the micro-cap pharmaceutical player.
Read MoreAnuh Pharma Declines 7.41%: Downgrade and Technical Weakness Drive the Slide
2026-10-24 15:01:27Key Events This Week 19 Oct: Stock opens at Rs.82.88 amid broad market weakness 21 Oct: Sharp decline of 3.61% to Rs.79.89 following technical concerns 22 Oct: Further drop of 1.00% to Rs.79.09 as downgrade announced 23 Oct: Week closes at Rs.76.90, down 2.77% on heavy volume Week OpenRs.83.05 Week Close<div class="st...
Read More
Anuh Pharma Ltd Downgraded to Sell Amid Technical Weakness and Flat Financials
2026-10-23 08:33:00Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 Oct 2026. This shift reflects a combination of deteriorating technical indicators, flat recent financial performance, and subdued long-term growth prospects, despite some attractive valuation metrics. The downgrade comes amid a challenging market environment and signals caution for investors considering exposure to this stock.
Read More
Anuh Pharma Ltd Faces Technical Momentum Shift Amid Bearish Indicators
2026-10-23 08:05:07Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This change is underscored by a downgrade in its Mojo Grade from Hold to Sell as of 22 Oct 2026, reflecting growing concerns over its near-term price trajectory despite some longer-term strengths.
Read More
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-10-06 08:05:58Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent dip in price, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid broader market volatility.
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Management
20-Nov-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that Mr. Amit Saratkar AGM - HR Strategy and Transformation designated as Senior Management Personnel has tendered his resignation vide letter dated 17th September 2026. The said resignation has been accepted by the management on 20th November 2026 and the resignation shall be effective from 30th November 2026.
Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Facility F-10/1 And Commencement Of Commercial Production Of The Company.
15-Nov-2026 | Source : BSEThis is to inform that the Company has inaugurated its new manufacturing facility situated at F-10/1 M.I.D.C. Tarapur Boisar District Palghar - 401506 Maharashtra India.
Announcement Under Regulation 30 (LODR) - Capacity Addition
15-Nov-2026 | Source : BSECapacity Addition by inauguration of the F-10/1 M.I.D.C. Tarapur Boisar District Palghar - 401506 Maharashtra India.
Corporate Actions
No Upcoming Board Meetings
Anuh Pharma Ltd has declared 30% dividend, ex-date: 05 Aug 26
Anuh Pharma Ltd has announced 5:10 stock split, ex-date: 31 Jul 06
Anuh Pharma Ltd has announced 1:1 bonus issue, ex-date: 15 Jul 25
No Rights history available